Good MorningEquity markets reversed two days of losses to advance to a new high on Wednesday following better-than-expected economic data. Investors cheered hot ISM services and Factory Orders data suggesting both aspects of the US economy are regaining momentum. If true, investors should also expect another uptick in inflation as demand puts added pressure on the economy.
In other news, oil prices continue to slide and fall below key support at the $96 level following a slight increase in production from OPEC. This move may trigger additional selling, but the worse news is the implication for the economy. Oil prices are not expected to contract without a major slow down in activity, and we've yet to see one. In this light, the decline in oil prices is either a precursor to a deeper economic recession or a whipsaw move and buying opportunity. Featured: This Bitcoin bull run is different… (Ad) 
|
Stocks | | |
Typically when a mature company’s share price is hovering around $20 or below, it means that growth prospects are limited. But that’s not always the case.
As we’ve seen during this year’s market downturn, even well-run, fundamentally sound companies can get dragged down wi... Read the Full Story |
|
From Our Partners | | Over a year ago, I went LIVE to reveal a brand new setup called “Automated Options” to the world — where all we needed to do was place a quick trade…
Wait for a couple of weeks…
And when everything worked out, we were able to walk away with $1,250 in extra income (with a $5k starting stake).
After showing my closed group of traders how to leverage this setup to find opportunities in any market condition…
I set out to look for a better, more straightforward way to target extra income in a fraction of time…
And what I found didn’t only help me supercharge these automated options…
But it also showed me how we can target income overnight — nearly every day the market is open!
The best part?
Unlike the automated options that take two weeks to target opportunities…
All you need is just two minutes to place a quick trade before the market close.
And if everything works out just as planned, you could walk away with extra cash in less than 24 hours!
Take March 19th for example.
If you had known about these overnight opportunities, you would’ve placed a quick trade with me…
And sure enough, it would’ve paid out $1,086 in overnight income. | | If you follow this link, you’ll see everything she has laid out, |
|
Politics | | | Stocks on Wall Street closed broadly higher Wednesday as investors welcomed encouraging economic data and quarterly earnings reports from big companies including Starbucks.
The S&P 500 rose 1.6% to an almost 2-month high, while the Nasdaq gained 2.6%. Both indexes more than recoup... Read the Full Story |
|
Politics | | | Stocks on Wall Street are extending their gains in afternoon trading Wednesday as investors review a mostly encouraging batch of quarterly earnings from several big companies.
The S&P 500 rose 1.7% as of 3:02 p.m. Eastern. The Dow Jones Industrial Average rose 453 points, or 1.4%,... Read the Full Story |
|
From Our Partners | | Ready to ride the next crypto wave? Our new ebook, "Crypto Boom Strategy", shares the ETFs and stocks that experienced investors are watching, ideal for those with a moderately aggressive investment approach. | | 👉 Click here to download your free ebook now! |
|
Stocks | | |
Devon Energy (NYSE:DVN) may be an overlooked company in the oil and gas sector. However, that may change after the company releases earnings this week. The $5.63 billion in revenue beat expectations by 18%. And on the bottom line, the news was equally impressive, with the company posting $2.59 ear... Read the Full Story |
|
Stocks | | |
The health care sector is just barely participating in the S&P 500’s nascent rally, but pharmaceuticals such as AbbVie (NYSE:ABBV), Merck (NYSE:MRK) and Pfizer (NYSE:PFE) are holding up well relative to the broader market.
All three reported earnings recently, and while none got a... Read the Full Story |
|
From Our Partners | | Elon's Next Market Move Could Send Silver Soaring
Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.
And now, whispers are growing that his next move could be in silver.
Why? Because silver is the lifeblood of EVs, solar panels, and AI tech. | | Smart money is already watching silver closely. |
|
Stocks | | |
Media entertainment company Warner Brothers Discovery (NYSE: WBD) stock has languished since its spin-off as it fell to new all-time lows at $12.77 and down (-41%) year-to-date. Formerly Discovery Networks, the merging with WarnerMedia has created a content powerhouse including popular brands like... Read the Full Story |
|
Markets | | |
The entire energy infrastructure complex is moving higher and Energy Transfer LP (NYSE: ET) may lead the bunch. The company’s diversified approach to energy and its reliance on fee-based income make it stand out from other energy companies and its own peers. Trading at 7.33X its earnings it ... Read the Full Story |
|
Tech | | | Toyota’s profit fell nearly 18% in the April-June quarter from the year before, as a semiconductor shortage that has slammed the auto industry dented production at Japan’s top automaker.
Toyota Motor Corp. reported Thursday a quarterly profit of 736.8 billion yen ($5.5 billion), down... Read the Full Story |
|
Politics | | | President Joe Biden traveled to Saudi Arabia last month on the possibility that he could get some additional oil production out of OPEC+ in coming weeks, but the cartel and other nations announced a scant increase Wednesday.
The White House responded by stressing that what matters is ... Read the Full Story |
|
Politics | | | President Joe Biden traveled to Saudi Arabia last month on the possibility that he could get some additional oil production out of OPEC+ in coming weeks — but the cartel and other nations announced a scant increase on Wednesday.
The White House responded by stressing that what matters... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada. | | View Today's Stock Pick |
|
